Skip to content

Net margin at other companies

Incyte logo
IncyteINCY
26.7%+26.2pp
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-7,965.8%-10,750pp
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-4,987.4%-8,966pp
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-612%+602pp
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-166.4%-195pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-49.9%-22.6pp

Other financials

Income statement

See full
Revenue$2.0M+37.2%
Gross profit$1.6M+68.7%
Operating income-$22.2M-22.7%
Net income-$19.8M-31.4%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$28.7M-5.6%
Total debt$2.0M-20.1%
Total equity$143.6M-0.3%
Total assets$198.7M+0.3%

Cash flow

See full
Operating cash flow-$18.1M-39.0%
CapEx$13.0K-69.8%
Free cash flow-$18.2M-38.6%

Valuation

See full
Market cap$685.75M+337%
Enterprise value$659.07M+410%
P/S82×+73.1×

Profitability

See full
Gross margin76.3%-9.7pp
Operating margin-961.9%+259pp
FCF margin-624.9%

Returns & leverage

See full
Return on equity-48.4%-15.4pp
Debt / equity0.0×
Current ratio-1.0×

Where this comes from

Calculated from Aclaris Therapeutics’s reported figures.

Based on trailing twelve months.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aclaris Therapeutics's net margin?
Aclaris Therapeutics (ACRS) reported net margin of -832.6% in Q1 2026.
How has Aclaris Therapeutics's net margin changed year-over-year?
Aclaris Therapeutics's net margin decreased by 13.7% year-over-year, from -732.4% to -832.6%.
What is the long-term trend for Aclaris Therapeutics's net margin?
Over 5 years (2020 to 2025), Aclaris Therapeutics's net margin has grown at a 1.1% compound annual growth rate (CAGR), from -787% to -829.6%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.